Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Precision Medicine Phase 2 Option 1
Key facts
- Who runs it
- University of California, San Francisco
- Where
- Milwaukee, Philadelphia, Pittsburgh, Salt Lake City, and San Francisco, United StatesSee the 5 sites
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 50 people, planned
- Started
- 1 Jun 2021
- Expected to end
- Apr 2030
- Type of study
- Observational
- Record updated
- 14 September 2026
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (23)Hide the full registry criteria
Who can take part
- Age 18 - 65y inclusive
- History or evidence of TBI, according to DoD-VA criteria
- Glasgow Coma Scale (GCS) 3 - 15 after resuscitation in the ED
- Head CT with evidence of trauma-related abnormality (except for isolated epidural hematoma (EDH))
- Ability to undergo MRI within 48 hours of injury
- Ability to obtain informed consent from participant or Legally Authorized Representative (LAR) within 6 hours of injury
- Fluency in English or Spanish
Who cannot take part
- History of pre-existing neurologic disorder, such as dementia, mild cognitive impairment, uncontrolled epilepsy, multiple sclerosis, strokes, brain tumors, prior severe TBI, or other disorder that may confound interpretation of MRI or neuropsychological results
- Acute ischemic heart disease (myocardial infarction or unstable angina)
- History of syncope or hypotension
- History or evidence of active malignancy
- History of pre-existing disabling mental illness, such as major depression or schizophrenia
- History or evidence of chronic heart failure or chronic renal failure
- Patients on psychiatric hold (e.g. 5150, 5250)
- Unstable respiratory or hemodynamic status
- Evidence of penetrating brain injury
- Isolated EDH as only trauma-related CT abnormality
- Systemic traumatic injury that would preclude participation in study, which is expected to result in long-term disability not related to TBI
- Evidence of serious infectious complications (sepsis, bacteremia, multilobar pneumonia)
- Systolic blood pressure (SBP) < 90 mm Hg, Diastolic blood pressure (DBP)< 40 mm Hg for longer than 5 minutes
- Low likelihood of follow-up (e.g., participant or family indicating low interest, residence in another state or country, unhoused or lack of reliable contacts)
- Women who are pregnant or breast-feeding
- Prisoners or patients in custody
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Traumatic brain injury
Where in United States
- Medical College of WisconsinMilwaukee, United StatesEnrolling by invitation
- University of Pennsylvania/Penn Presbyterian Medical CenterPhiladelphia, United StatesEnrolling by invitation
- University of Pittsburgh Medical CenterPittsburgh, United StatesEnrolling by invitation
- University of UtahSalt Lake City, United StatesEnrolling by invitation
- University of California San FranciscoSan Francisco, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
This study is being conducted to validate early and ultra-early blood-based and novel imaging biomarkers of Diffuse Axonal Injury (DAI), Microvascular Injury (MVI), and neuroinflammation that may serve as predictive and pharmacodynamic biomarkers in a new cohort of moderate-severe TRACK-TBI subjects. The study team will enroll a cohort of moderate to severe TBI subjects (N=50), stratified according to VA/DoD criteria for these injury severities through the existing TRACK-TBI network sites to obtain novel advanced neuroimaging and more frequent biomarker sampling. Subjects will be assessed over 3 months.
The group in the trial
- Moderate to Severe TBI Subjects
Adult patients (age 18-65y inclusive) presenting to the Emergency Department (ED) with a history of acute TBI as per American Congress of Rehabilitation Medicine (ACRM) Criteria (i.e., patient has sustained a traumatically-induced physiological disruption of brain function).
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- TRACK-TBI Precision Medicine Phase 2-Option I
- Criteria questions
- Built from NCT04602806, who can take part
- Publications
- Record updated
- 14 September 2026